At TCG Labs-Soleil, we are establishing a pioneering venture-biotech model in collaboration with The Column Group. Our mission is to efficiently translate scientific insights into therapeutic solutions for patients facing serious diseases. Our approach integrates a dedicated venture fund (TCG Labs) with an evergreen R&D hub led by top-tier scientists (Soleil). This creates a powerful ecosystem forming and overseeing independent portfolio companies, each dedicated to single-asset biologic programs, guiding them from ideation to clinical proof of concept and positioning them for strategic partnerships and transformative medical advancements.

Biotechnology

Health Care

Life Sciences

Venture Capital

TCG Labs-Soleil

Jin-Long Chen

Harding L.

Kathy Miller

Sarah Hymowitz

Lucinda Quan

Josh Lichtman

Hui Tian

Corinne Foo - Atkins

Harding Luan

Tim Kutzkey

The Leadership Team at TCG Labs-Soleil is responsible for steering the strategic vision and operational execution of the company. Comprising senior executives and co-founders, this team ensures the seamless integration of venture funding and scientific research efforts. They oversee the development and management of independent portfolio companies, guiding each biologic program from inception through to clinical proof of concept, with the ultimate aim of achieving transformative medical advancements and establishing strategic partnerships.

Leadership Team

Academic and Science Team

Research and Development

Leadership Team

About

Team members

Other teams at TCG Labs-Soleil

Academic and Science Team

Research and Development